Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
The FDA is alerting consumers that there is an Invokana amputation risk associated with the popular diabetes drug.
The FDA is now requiring a black box warning on the label so that consumers are aware of the foot and leg amputation risk.
Following the FDA-mandated CANVAS trial (1), which found that Invokana doubled the risk of lower limb amputations compared with patients taking a placebo, many healthcare providers have decided to stop prescribing the diabetes drug.
The CANVA trials started in 2009.
Initially, the trials showed beneficial results that prompted the FDA to approve Invokana in 2013.
But, recent studies show that Invokana side effects include more than amputation.
They also include the life-altering side effects of kidney damage and diabetic ketoacidosis.
According to the Canva study, half of the amputations observed were of toes, while the remainder included the foot, above the ankle, below the knee and above the knee.
Because Invokana is prescribed to people with Type-2 diabetes, patients are already at a higher risk for amputation.
The study showed that patients that have already undergone amputation are at a much higher risk of secondary amputation if they are taking Invokana
In mid-May, following the CANVA results, the FDA ordered Invokana to carry a new black-box label warning patients of the increased risks of lower limb amputations.
The warning urged patients using Invokana to contact their doctor “right away” if they experience any pain or tenderness, sores, ulcers, or infections in their legs or feet.
Though the author of the CANVA study says that the drug does show success in reducing the risk of cardiovascular events, the newly associated risks of amputation has led healthcare providers to take preemptive measures to avoid future amputation lawsuits brought upon by patients affected by Invokana.
To avoid the threat of amputation lawsuits, doctors have begun to use alternative treatments for Type-2 diabetes patients.
Some healthcare providers have also started to substitute prescriptions for current Invokana users.
The focus is mostly on patients with predisposed conditions that put them at a higher risk of amputation, such as patients who have previously undergone amputation.
While a number healthcare systems have now taken Invokana off of their list of drug treatments for hospitalized patients, the popularity of the drug still puts many Type-2 diabetes patients at risk.
TruLaw urges all patients on Invokana to speak to a healthcare provider about the Invokana amputation risk.
Please do not stop taking any medications until you have spoken to your physician or healthcare provider.
It is estimated that 4.5 million Invokana prescriptions were filled in 2016 in the United States, alone.
However, it is expected that the FDA’s black box warning will cause a huge decrease in sales of Invokana as the number of prescriptions will decrease significantly as it will likely alarm patients.
There is no indication that manufacturer Janssen — a subsidiary of Johnson & Johnson pharmaceutical — plans on taking the current form of Invokana off the market.
Invokana lawsuits are currently being filed on behalf of individuals who were injured while taking Invokana.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Austin, Kentucky-based Kenny’s Farmhouse Cheese has recalled batch 231129 of its St. Jerome cheese after routine testing conducted by the Kentucky Department of Public Health showed the organism Listeria monocytogenes to be present in a single package, reports the FDA. While healthy people infected with
East Windsor, New Jersey-based Aurobindo Pharma USA, Inc. has recalled a single lot of Healthy Living Migraine Relief, Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets on behalf of AuroHealth because the product does not have a manufacturer label, reports the FDA. The voluntary,
Indio, California-based Stutz Packing Company has recalled its 1-pound bags of shelled walnuts because a potential Listeria monocytogenes contamination has been identified in the product, reports the FDA. While healthy people infected with the organism may only experience short-lived symptoms like “high fever, severe headache,